Inaugural HIV Inhibitors
1775 East Mission Bay Drive
San Diego, CA 92109
Keywords: Inaugural HIV Inhibitors, Cambridge Healthtech Institute, HILTON SAN DIEGO RESORT

Schedule of Presentations:

Tuesday, April 7, 2009
12:30:00 Registration
13:30:00 Chairperson’s Opening Remarks
13:40:00 KEYNOTE PRESENTATION: The Discovery of Novel HIV Integrase Inhibitors Joseph P. Vacca
13:40:00 KEYNOTE PRESENTATION: The Discovery of Novel HIV Integrase Inhibitors Joseph P. Vacca
14:10:00 Featured Presentation: Reverse Transcriptase-Associated Ribonuclease H Activity as a Therapeutic Target Stuart F.J. Le Grice
14:40:00 UpDate on Antiretroviral Programs at Gilead Sciences Christian D. Callebaut
15:10:00 Selected Oral Poster Presentation
15:25:00 Networking Refreshment Break in the Exhibit Hall
16:05:00 MPC-4326 (Bevirimat dimeglumine): a First-in-Class HIV-1 Maturation Inhibitor Vijay Baichwal
16:35:00 Novel Metallodrugs Targeting HIV RNA and Proteases James Cowan
17:05:00 Informal Breakout Discussions with the Experts
17:10:00 Topic 12: The Future of Natural Products in Drug Discovery Bart DeCorte
17:15:00 Topic 13: Public/Shared Resources and Databases to Facilitate Fast and Accurate Assessment and Lessons from the Past Talapady Bhat
17:20:00 Topic 14: Increasing the Barrier to Drug Resistance by Targeting Viral Cellular Interactions John Howe
17:25:00 Topic 21: The Challenge of Developing New Classes of HIV Therapeutic Agents Vijay Baichwal
18:15:00 End of Day
Wednesday, April 8, 2009
07:45:00 Morning Coffee
08:15:00 KEYNOTE PRESENTATION: The Discovery of Two Generations of HIV Protease Inhibitors for the Treatment of HIV Infection Hing L Sham
08:15:00 Chairperson’s Remarks
09:00:00 Featured Presentation: The Discovery of Intelence®, an Important Advance in the Treatment of HIV Bart DeCorte
09:30:00 Brief History of the Development of Ziagen Robert Vince
10:00:00 Networking Coffee Break in the Exhibit Hall
10:45:00 Dual Inhibition of Both HIV and HCV Replication by Novel 2’-Deoxy-Nucleoside Analogs Klaus Klumpp
11:15:00 The Discovery of RDEA806 – An NNRTI Inhibitor Currently in Phase II Jean-Luc Girardet
11:45:00 Discovery and Validation of a New Generation of Novel-Target HIV Inhibitors Scott L. Butler
12:15:00 Luncheon in the Exhibit Hall (Last chance for exhibit viewing)
13:55:00 Chairperson’s Remarks
14:00:00 The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors Ira Dicker
14:30:00 Binders to HIV-1 RT: Approaches to Improve Mutant Profile and Oral Bioavailability Todd Elworthy
15:00:00 Networking Refreshment Break
15:20:00 Screening for Inhibitors of HIV Integrase - LEDGF/p75 Interaction John Howe
15:50:00 Structural Database using Semantic Web Concepts to Support Structure-Based Drug Design for AIDS Talapady Bhat
16:20:00 Prediction of HIV-1 Integrase Inhibitory Activity Jinhua Zhang
16:50:00 End of Conference
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.